The FDA-Approved Drug Pyrvinium Selectively Targets ER⁺ Breast Cancer Cells with High INPP4B Expression

Samuel J. Rodgers
, Lisa M. Ooms
, Christina A. Mitchell

Research output: Contribution to journal › Article › Research › peer-review

6 Citations (Scopus)

1 results

Finished

Characterisation of a novel oncogene in breast cancer
Mitchell, C. (Primary Chief Investigator (PCI)), Ellisdon, A. (Chief Investigator (CI)) & McLean, C. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/16 → 31/12/21
Project: Research